Protagonist Therapeutics Inc buy Citigroup Inc.
Start price
10.11.25
/
50%
€74.00
Target price
10.11.26
€84.79
Performance (%)
63.51%
Price
28.07.26
€121.00
Summary
This prediction is currently active. With a performance of 63.51% the BUY prediction by Citigroup_Inc_ is a big success. This prediction currently runs until 10.11.26. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Protagonist Therapeutics Inc | 2.542% | 2.542% |
| iShares Core DAX® | 1.717% | 3.368% |
| iShares Nasdaq 100 | -4.565% | -4.238% |
| iShares Nikkei 225® | -7.120% | -11.869% |
| iShares S&P 500 | -0.894% | 1.687% |
Comments by Citigroup_Inc_ for this prediction
In the thread Protagonist Therapeutics Inc diskutieren
Protagonist Therapeutics (NASDAQ:PTGX) had its price target raised by analysts at Citigroup Inc. from $96.00 to $98.00. They now have a "buy" rating on the stock.
Ratings data for PTGX provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for Protagonist Therapeutics Inc
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€124.00
17.07.26
17.07.26
-
17.07.27
17.07.27
-2.42%
28.07.26
28.07.26
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€88.00
19.03.26
19.03.26
€108.80
19.03.27
19.03.27
37.50%
28.07.26
28.07.26
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€43.60
07.08.25
07.08.25
-
07.08.26
07.08.26
177.52%
28.07.26
28.07.26
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€46.40
17.06.25
17.06.25
€62.32
17.06.26
17.06.26
112.28%
18.06.26
18.06.26